Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Teijin reports naphthalene derivatives with immunosuppresive activity

July 19, 1996

Immunosuppressants reported by DuPont Merck

July 19, 1996

American Home Products issued U.S. patent for 42-epi-rapamycin

July 19, 1996

Positive safety, efficacy profile of HMG-CoA reductase inhibitors in hyperlipidemia treatment

July 12, 1996

ICOS issued U.S. patent relating to ICAM-3

July 12, 1996

TCV-309: Potential agent for transplantation of ischemically injured kidney

July 12, 1996

GT32-B: a novel antibacterial/antitumor immunosuppresant

July 12, 1996

Sankyo reveals potential immunosupressants

July 12, 1996

Immunosuppressive and antiinflammatory agents from Italfarmaco

July 12, 1996

Dacliximab receives patent protection in U.S.

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...